(WELL) WELL Health Technologies - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA94947L1022

WELL: Electronic, Medical, Records, Telehealth, Software, Billing, Cybersecurity

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company operating in Canada, the United States, and internationally. It delivers omni-channel patient services and solutions across specialized markets, including medical recruitment, anesthesia, gastrointestinal health, and primary care. The company also develops and integrates its own suite of technology solutions for healthcare providers, including Electronic Medical Records (EMR) systems like OSCAR, Juno, Profile (Intrahealth), and Cerebrum (AwareMD). Its platform offers telehealth services, practice management tools, AI-powered virtual assistants (WELL AI Voice), billing and revenue cycle management solutions, and cybersecurity protections for patient data. WELL Health has expanded its capabilities through strategic acquisitions, building a comprehensive ecosystem that supports healthcare practitioners and clinics. Founded in 2010 and headquartered in Vancouver, Canada, the company has established itself as a key player in the digital transformation of healthcare services.

From a technical perspective, WELL Healths stock (TO:WELL) is currently trading at $3.95, below its 20-day SMA of $4.01, suggesting short-term downward momentum. The stocks 50-day and 200-day SMAs of $4.75 and $4.90, respectively, indicate a broader downtrend. The average trading volume over 20 days is 844,800 shares, with an ATR of $0.24, reflecting moderate volatility. On the fundamental side, the companys market cap stands at $948.40M CAD, with a P/E ratio of 28.85 and a forward P/E of 10.00, signaling expectations of future earnings growth. The P/B ratio of 1.09 and P/S ratio of 1.03 suggest the stock is reasonably valued relative to its book value and sales. However, the RoE of 3.76% indicates room for improvement in profitability. Overall, while the stock may face near-term headwinds, its valuation metrics and growth prospects could attract long-term investors seeking exposure to the digital healthcare sector.

Additional Sources for WELL Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

WELL Stock Overview

Market Cap in USD 724m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

WELL Stock Ratings

Growth Rating 86.4
Fundamental 47.9
Dividend Rating 0.0
Rel. Strength 62.6
Analysts -
Fair Price Momentum 5.09 CAD
Fair Price DCF -

WELL Dividends

No Dividends Paid

WELL Growth Ratios

Growth Correlation 3m -96%
Growth Correlation 12m 73.3%
Growth Correlation 5y 87.7%
CAGR 5y 79.58%
CAGR/Max DD 5y 1.63
Sharpe Ratio 12m -0.08
Alpha 35.46
Beta 2.115
Volatility 48.93%
Current Volume 939.7k
Average Volume 20d 772.9k
What is the price of WELL stocks?
As of May 09, 2025, the stock is trading at CAD 3.89 with a total of 939,685 shares traded.
Over the past week, the price has changed by -1.77%, over one month by -2.75%, over three months by -36.33% and over the past year by +56.01%.
Is WELL Health Technologies a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, WELL Health Technologies (TO:WELL) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.87 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WELL as of May 2025 is 5.09. This means that WELL is currently undervalued and has a potential upside of +30.85% (Margin of Safety).
Is WELL a buy, sell or hold?
WELL Health Technologies has no consensus analysts rating.
What are the forecast for WELL stock price target?
According to ValueRays Forecast Model, WELL WELL Health Technologies will be worth about 6 in May 2026. The stock is currently trading at 3.89. This means that the stock has a potential upside of +53.47%.
Issuer Forecast Upside
Wallstreet Target Price 7.9 102.1%
Analysts Target Price - -
ValueRay Target Price 6 53.5%